Francois Nader's Net Worth

$43.7 Million

Estimate Recalculated Jul 19, 2024 06:01PM EST

Who is Francois Nader?

Francois Nader has an estimated net worth of $43.7 Million. This is based on reported shares across multiple companies, which include Moderna, Inc., Talaris Therapeutics, Inc., Prevail Therapeutics Inc., TREVENA INC, Baxalta Inc, NPS PHARMACEUTICALS INC, ACCELERON PHARMA INC, ALEXION PHARMACEUTICALS, INC., and NOVEN PHARMACEUTICALS INC.

SEC CIK

Francois Nader's CIK is 0001365343

Past Insider Trading and Trends

2013 was Francois Nader's most active year for acquiring shares with 39 total transactions. Francois Nader's most active month to acquire stocks was the month of January. 2013 was Francois Nader's most active year for disposing of shares, totalling 44 transactions. Francois Nader's most active month to dispose stocks was the month of January. 2019 saw Francois Nader paying a total of $1,087,081.83 for 92,832 shares, this is the most they've acquired in one year. In 2015 Francois Nader cashed out on 1,595,748 shares for a total of $13,877,663.10, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Moderna, Inc. (MRNA) Snapshot price: $99.19

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
May 3
Form 4
+2,831.29%
19.9K
$77.49
$921.40
20.61K
Scheduled
May 10
Form 4
∞
703
—
—
703
Apr 28
Form 4
—
0
—
—
0
Apr 28
Form 4
—
0
—
—
0
Apr 29
Form 4
—
0
—
—
0
Dec 10
Form 3
—
0
—
—
0
No matching records found

Talaris Therapeutics, Inc. (TRML) Snapshot price: $35.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4/A
+35.00%
138.5K
$3.61
$500,020.00
534.19K
Jul 19 - Jul 25
Form 4
+41.20%
138.5K
$3.61
$500,020.00
474.67K
Jul 19 - Jul 25
Form 4
—
0
—
—
0
Jun 9
Form 4
-15.04%
-59.52K
—
—
336.17K
Dec 15
Form 3
—
0
—
—
0
No matching records found

Prevail Therapeutics Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-23.75K
—
—
0
Jan 22
Form 4
—
0
—
—
0
Jun 17
Form 4
∞
23.75K
—
—
23.75K
Jun 24
Form 3
—
0
—
—
0
No matching records found

TREVENA INC (TRVN) Snapshot price: $0.582

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
Jan 30
Form 3
—
0
—
—
0
No matching records found

Baxalta Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-7.66K
—
—
0
Jun 3
Form 4
+142.54%
4.5K
—
—
7.66K
May 10
Form 4
-50.00%
-3.14K
—
—
3.14K
Jul 27
Form 3
—
0
—
—
0
No matching records found